DiaSorin S.p.A.
General ticker "DSRLF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $5.0B (TTM average)
DiaSorin S.p.A. does not follow the US Stock Market performance with the rate: -35.4%.
Estimated limits based on current volatility of 2.1%: low 68.43$, high 71.32$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2025-05-20, amount 1.35$ (Y2.01%)
Short-term DSRLF quotes
Long-term DSRLF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,148.21MM | €1,185.43MM | €1,194.55MM |
| Operating Expenses | €931.95MM | €927.10MM | €966.64MM |
| Operating Income | €216.26MM | €258.32MM | €227.91MM |
| Non-Operating Income | €-15.04MM | €-15.88MM | €-15.99MM |
| Interest Expense | €29.34MM | €28.61MM | €16.99MM |
| R&D Expense | €90.95MM | €91.57MM | €0.00MM |
| Income(Loss) | €201.22MM | €242.45MM | €211.92MM |
| Taxes | €42.71MM | €55.39MM | €61.98MM |
| Profit(Loss)* | €159.85MM | €188.10MM | €149.85MM |
| Stockholders Equity | €1,538.61MM | €1,800.92MM | €1,584.49MM |
| Inventory | €315.50MM | €344.04MM | €334.60MM |
| Assets | €3,211.44MM | €3,304.92MM | €2,873.16MM |
| Operating Cash Flow | €311.66MM | €358.78MM | €342.76MM |
| Capital expenditure | €45.47MM | €119.72MM | €137.68MM |
| Investing Cash Flow | €-29.10MM | €-49.81MM | €-144.52MM |
| Financing Cash Flow | €-235.96MM | €-259.13MM | €-351.18MM |
| Earnings Per Share** | €2.87 | €3.37 | €2.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.